Cargando…

Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis

BACKGROUND: Treatment for pancreatic neuroendocrine tumors (PNETs) in patients with unresectable metastatic liver disease has long been a controversial issue. This systematic review aims to summarize the existing evidence concerning the value of primary tumor resection in this group of patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bo, Zhan, Canyang, Ding, Yuan, Yan, Sheng, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827741/ https://www.ncbi.nlm.nih.gov/pubmed/29503572 http://dx.doi.org/10.2147/OTT.S158171

Ejemplares similares

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors
por: Zhou, Bo, et al.
Publicado: (2017)

Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection
por: Zhou, Bo, et al.
Publicado: (2017)

Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection
por: Zhou, Bo, et al.
Publicado: (2019)

Laparoscopic spleen-preserving pancreatic resection for epidermoid cyst in an intrapancreatic accessory spleen: case report and literature review
por: Zhou, Bo, et al.
Publicado: (2018)

The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases
por: Mou, Yu, et al.
Publicado: (2022)

Predictors of Long-Term Outcomes After Liver Transplantation for Unresectable Metastatic Neuroendocrine Tumors
por: Kuncewicz, Mikołaj, et al.
Publicado: (2023)

Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
por: Feng, Tingting, et al.
Publicado: (2019)

Palliative resection of a primary tumor in patients with unresectable colorectal cancer: could resection type improve survival?
por: Jang, Hyun Seok, et al.
Publicado: (2016)

Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2022)

Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases
por: Tao, Lianyuan, et al.
Publicado: (2017)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study
por: Huang, Xi-Tai, et al.
Publicado: (2023)

Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis
por: Zhang, Rong-xin, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
por: Devata, Sumana, et al.
Publicado: (2012)

Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
por: Wiedmann, Marcus W., et al.
Publicado: (2012)

Prognostic factors of long-term outcome in surgically resectable pancreatic neuroendocrine tumors: A 12-year experience from a single center
por: Zhou, Bo, et al.
Publicado: (2017)

Palliative Interventional and Surgical Therapy for Unresectable Pancreatic Cancer
por: Assfalg, Volker, et al.
Publicado: (2011)

Novel EUS-guided microwave ablation of an unresectable pancreatic neuroendocrine tumor
por: Robles-Medranda, Carlos, et al.
Publicado: (2022)

Successful palliative peptide receptor radionuclide therapy for impending compression of vena cava due to unresectable liver metastasis of neuroendocrine tumor
por: Ataeinia, Bahar, et al.
Publicado: (2019)

Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer
por: Shin, Ji Eun, et al.
Publicado: (2023)

Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
por: Guo, Jingfei, et al.
Publicado: (2016)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations
por: Xu, Midie, et al.
Publicado: (2022)

Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
por: Ergun, Yakup, et al.
Publicado: (2020)

Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer
por: Karapanos, Konstantinos, et al.
Publicado: (2011)

Ectopic spleen and liver hemangioma mimicking metastatic pancreatic neuroendocrine tumor
por: Engler, Christine C., et al.
Publicado: (2015)

A novel scoring system predicting survival benefits of palliative primary tumor resection for patients with unresectable metastatic colorectal cancer: A retrospective cohort study protocol
por: Cao, Gaoyang, et al.
Publicado: (2019)

Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer
por: Xu, Jing, et al.
Publicado: (2019)

Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer
por: Yang, Yi, et al.
Publicado: (2020)

Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
por: Zhang, Jing, et al.
Publicado: (2019)

Palliative Resection of Pancreatic Adenocarcinoma
por: Johnson, C. D.
Publicado: (1995)

Metastatic neuroendocrine pancreatic tumor – Case report
por: Radu, EC, et al.
Publicado: (2018)

Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy
por: Addeo, Pietro, et al.
Publicado: (2022)

Resection and thermal hepatic ablation of pancreatic neuroendocrine tumor liver metastases for prolonged survival
por: Ke, Xindi, et al.
Publicado: (2022)

Adaptive Tomotherapy for locally advanced unresectable pancreatic neuroendocrine tumor: Case report and literature review
por: Tu, Kuan-Yi, et al.
Publicado: (2022)

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
por: Ito, Tetsuhide, et al.
Publicado: (2017)

Phase I/II study of streptozocin monotherapy in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors
por: Komoto, Izumi, et al.
Publicado: (2022)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
por: Shen, Chaoyong, et al.
Publicado: (2014)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms
por: Tong, Zhou, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_if7sl3dd6vgvpqr6c506uupvbu